Setting new standards in information exchange for the pharmaceutical and biotech industry
Biotech Founder CMO, Dr Pam Palmer on Highlights at the November Physician Executives in Life Science Event
October 14, 2015
Conference Director, Kate Woda sat down with Co-Chair Pam Palmer to discuss what she expects from this year’s Chief Medical Officer Summit West.
A: I’m excited for all the new topics of discussion and the new speakers this year. I am glad that the CMO West conference continues to remain fresh and current for both new and returning attendees.
Q: What do you want attendees to walk away with at CMO West?
A: CMO West is a group effort with both speakers and attendees playing key roles. I would like all CMO West participants to feel engaged and energized after this year’s conference but to also look towards next year, and to recommend even more new topics and speakers.
Q: What session stands out to you and why?
A: I am especially interested in hearing Laurie Burke, Former Director of Study Endpoints and Labeling Development at the FDA, speak in the session entitled “Measurement of Treatment Benefit in an Era of Patient-Focused Drug Development”. This is both a new speaker and a new topic for CMO West and her insights into clinical trial endpoints and overall measurement of treatment benefit should be quite timely.
Learn more about the event here: http://theconferenceforum.org/conferences/cmo-summit-west/overview/